• Shionone Activates Mitophagy to Counter Pulmonary Fibrosis

  2026-08-05

  This study demonstrates that Shionone, a terpenoid from Ligularia fischeri, mitigates pulmonary fibrosis by stimulating mitophagy via the PINK1-Parkin pathway. The findings highlight a novel mechanism that links mitochondrial quality control and redox regulation to anti-fibrotic therapy, offering new directions for pulmonary fibrosis research.

• H. pylori-Induced HNF4A Silencing Drives EMT in Gastric Canc

  2026-08-05

  The referenced study elucidates how Helicobacter pylori infection leads to promoter hypermethylation and silencing of the tumor suppressor gene HNF4A in gastric epithelial cells. This epigenetic alteration drives loss of cell polarity and activates EMT signaling, promoting gastric cancer development and metastasis, and highlights the importance of DNA demethylation agents for mechanistic cancer studies.

• Plerixafor (AMD3100): Protocols for Cancer and Stem Cell Res

  2026-08-04

  Plerixafor (AMD3100) empowers researchers to dissect CXCL12/CXCR4 signaling in cancer metastasis inhibition, stem cell mobilization, and immune modulation. This guide distills workflow enhancements, troubleshooting, and the latest insights from cutting-edge studies—enabling precise, reproducible results with APExBIO’s trusted reagent.

• Canagliflozin and Mitochondrial Modulation: New Horizons in

  2026-08-04

  Explore how Canagliflozin, a potent SGLT2 inhibitor, advances diabetes research by modulating mitochondrial function and structure in renal cells. This in-depth review provides unique mechanistic insights and practical guidance for leveraging Canagliflozin in metabolic disease models.

• Dual-Action p38α MAPK Inhibition: Mechanism and Implications

  2026-08-03

  The reference study reveals that certain kinase inhibitors, including those targeting p38α MAPK, not only block kinase activity but also accelerate dephosphorylation by phosphatases via conformational modulation. This dual-action mechanism, resolved at atomic detail, opens new avenues for designing more potent and selective research tools in inflammation and apoptosis studies.

• Adiponectin Shields Aging Rats from Surgery-Induced Cognitiv

  2026-08-03

  This study demonstrates that adiponectin administration can reverse cognitive decline following splenectomy in aged rats by inhibiting the TLR4/MyD88/NF-κB pathway, thereby reducing neuroinflammation and oxidative stress. The findings provide mechanistic insights into perioperative neurocognitive disorder (PND) and highlight therapeutic strategies relevant to neuroimmune modulation in aging.

• Volumetric Two-Photon Imaging in Freely Moving Mice: miniBB2

  2026-08-02

  This study introduces the miniBB2p, a miniature Bessel-beam two-photon microscope that enables high-throughput, volumetric calcium imaging in freely moving mice. By overcoming previous technical barriers, this approach allows real-time visualization of activity in over 1000 neurons, providing new opportunities for understanding neural circuit dynamics during natural behaviors.

• Zolmitriptan: Applied 5-HT1B Receptor Agonist in Migraine Re

  2026-08-01

  Zolmitriptan is a high-purity 5-HT1B receptor agonist uniquely suited for migraine and cluster headache research, offering robust solubility and reproducibility in experimental designs. This article unpacks advanced workflows, protocol optimizations, and troubleshooting strategies to empower researchers leveraging Zolmitriptan for neurovascular investigations.

• Mechanistic Precision: DMG-PEG2000-NH2 for Next-Gen LNPs

  2026-07-31

  Explore how DMG-PEG2000-NH2 transforms lipid nanoparticle (LNP) and liposomal drug delivery. This article bridges mechanistic understanding with translational strategy, referencing recent antimycobacterial breakthroughs and scenario-driven workflow optimization. Learn how APExBIO’s NH2-PEG derivative advances bioconjugation, reproducibility, and clinical potential—moving beyond standard product pages and into the realm of thought leadership.

• Palmitic acid (Hexadecanoic Acid): Technical Use and Protoco

  2026-07-31

  Palmitic acid (SKU N2456) provides a high-purity, saturated long-chain fatty acid essential for reproducible research into lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It is not suitable for protocols requiring aqueous solubility or long-term storage of solutions; proper dissolution and immediate use are critical for experimental success.

• Chaperone-Mediated Autophagy Decline Drives Myopathy with Ag

  2026-07-30

  A recent study in Nature Metabolism reveals that age-related decline of chaperone-mediated autophagy (CMA) in skeletal muscle directly contributes to progressive myopathy. By dissecting the regulatory role of CMA in muscle proteostasis and function, the paper provides crucial insights into age-associated muscle deterioration, suggesting that restoring CMA activity could ameliorate myopathic phenotypes.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-07-30

  This study elucidates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetic profiles and tissue distribution of key alkaloids from Corydalis saxicola Bunting. By dissecting the impact of pathological status on drug metabolizing enzymes and transporters, it provides mechanistic insight for optimizing therapeutic strategies in MASLD/MASH contexts.

• Bovine Insulin in Neuronal Energy Homeostasis: Advanced Insi

  2026-07-29

  Explore how bovine insulin orchestrates energy regulation in neurons, revealing novel protocol considerations for cell culture and disease modeling. This article offers a distinct, science-driven perspective on insulin from bovine pancreas and its emerging roles beyond traditional applications.

• Molidustat (BAY85-3934): Mechanistic Insights for Next-Gen R

  2026-07-29

  Explore how Molidustat (BAY85-3934) enables advanced, physiologically relevant research in chronic kidney disease anemia by leveraging precise HIF stabilization and in-depth mechanistic understanding. This article uniquely connects molecular inhibition, assay design, and translational implications.

• HBTU: Advancing Peptide Bond Formation in Cancer-Selective S

  2026-07-28

  HBTU’s unmatched efficiency and resistance to racemization make it the coupling reagent of choice for precision peptide therapeutics. Discover how optimized protocols and troubleshooting strategies empower researchers to assemble complex, enzyme-responsive peptides with high yield and selectivity.

15417 records 1/1028 page Next 12345 下5页 Last page